Are PT (Prothrombin Time) and INR (International Normalized Ratio) results of 16.6 seconds and 1.51, respectively, normal for a patient with a recent femur fracture and daily aspirin (acetylsalicylic acid) use for myocardial infarction prevention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 21, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Are These PT/INR Results Normal?

No, these results are not normal—the PT is elevated at 16.6 seconds (reference 9.6-12.6) and the INR is elevated at 1.51 (reference 0.87-1.13), but these values are clinically insignificant and require no intervention in this patient taking only aspirin for MI prevention with a recent femur fracture. 1, 2

Understanding the Results in Clinical Context

Why These Values Are Elevated But Not Concerning

  • PT/INR is designed specifically to monitor vitamin K antagonist (warfarin) therapy, not to predict bleeding risk in patients not taking warfarin 1, 2
  • Your patient is taking only baby aspirin (acetylsalicylic acid), which does not affect PT/INR values 1
  • INR values between 1.0-2.0 in patients not on anticoagulation have no proven clinical significance and do not predict bleeding risk 2, 3
  • A systematic review found weak or no association between pre-procedural INR and bleeding in 78 out of 79 studies, with sensitivity under 50% 2

What Could Cause This Mild Elevation

The mild PT/INR elevation (1.51) in a non-anticoagulated patient may reflect:

  • Laboratory variability including thromboplastin reagent differences, collection tube issues, or automated detection methods 1
  • Early liver dysfunction affecting synthesis of clotting factors, though this would typically require more significant elevation 1, 3
  • Consumption of coagulation factors from the acute trauma (femur fracture), though again this is a very mild elevation 1

Management Recommendations

No Treatment Required

  • For asymptomatic patients with INR 1.0-2.0 not on anticoagulation, observation only is recommended—plasma transfusion provides no clinical benefit 3
  • Do not transfuse plasma to "correct" this INR value, as randomized trials found no reduction in bleeding when prophylactic plasma was given for mildly elevated INR 2

Perioperative Considerations for Femur Fracture Surgery

  • Aspirin monotherapy does not require discontinuation prior to orthopedic surgery for femur fracture 4
  • Surgery should proceed within 24 hours as planned to reduce mortality and morbidity 4
  • Neuraxial anesthesia is safe when the patient is taking aspirin 4
  • Aspirin is effective VTE prophylaxis for ambulatory patients with femoral neck fracture undergoing hip arthroplasty 5

What to Monitor Instead

  • Clinical bleeding signs rather than laboratory values 2, 3
  • Platelet count, fibrinogen level, and aPTT as part of comprehensive coagulation assessment if bleeding occurs 2
  • Consider viscoelastic testing (TEG/ROTEM) if available for more accurate coagulation assessment in trauma patients, as standard PT/INR represents only the first 4% of thrombin production 2

Common Pitfalls to Avoid

  • Do not use PT/INR as a general screening test for coagulopathy in non-warfarin patients—it lacks validity for this purpose and leads to unnecessary interventions 1, 2
  • Do not delay necessary surgery to "normalize" this INR value—early surgery within 24 hours improves outcomes in femur fracture patients 4
  • Do not assume this INR predicts bleeding risk—the INR scale is only validated for patients on vitamin K antagonists with no other superimposed coagulation defects 1
  • Do not discontinue aspirin perioperatively—current evidence supports continuing aspirin through orthopedic trauma surgery 4, 5

Post-Operative Anticoagulation

  • Resume or continue aspirin 75-162 mg daily indefinitely for MI prevention 6
  • Consider aspirin as VTE prophylaxis post-operatively rather than more potent anticoagulation in standard-risk ambulatory patients 5
  • If warfarin becomes indicated post-operatively (e.g., atrial fibrillation develops), target INR 2.0-3.0 6, 3

References

Guideline

Deflazacort's Effect on Coagulation Pathways

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Coagulation Factor Targets for Central Procedures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Deranged Prothrombin Time/International Normalized Ratio (PT/INR)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.